Results 101 to 110 of about 4,563 (204)
Lysophosphatidylinositols, from Cell Membrane Constituents to GPR55 Ligands
Lysophosphatidylinositols (LPIs) are membrane constituents that alter the properties of said membranes. However, recent data showing that the once orphan receptor, GPR55, can act as a receptor for LPIs has sparked a renewed interest in LPIs as bioactive ...
Al Houayek, Mireille +5 more
core +1 more source
Epileptic Disorders, Volume 28, Issue 4, Page 1285-1289, August 2026.
Anita N. Datta
wiley +1 more source
New blood brothers: the GPR55 and CB2 partnership [PDF]
Endocannabinoids are increasingly being recognized as key lipid-derived regulators of immune function 1. Although the peripheral cannabinoid type 2 receptor (CB2) is thought to orchestrate many of these actions, additional non-CB1/CB2-mediated effects of cannabinoids have been identified in immune cells 1, 2, where several orphan G protein-coupled ...
openaire +3 more sources
Although strokes are frequent and severe, treatment options are scarce. Plasminogen activators, the only FDA-approved agents for clot treatment (tissue plasminogen activators (tPAs)), are used in a limited patient group.
Sachin Gajghate, Hongbo Li, Slava Rom
doaj +1 more source
GPR55: a new promising target for metabolism?
GPR55 is a G-protein-coupled receptor (GPCR) that has been identified as a new cannabinoid receptor. Given the wide localization of GPR55 in brain and peripheral tissues, this receptor has emerged as a regulator of multiple biological actions ...
Rubén Nogueiras +6 more
core +1 more source
Peptide-guided targeting of GPR55 for anti-cancer therapy
Purpose: Expression of the lysophosphatidylinositol receptor GPR55 correlates with invasive potential of metastatic cells and bone metastasis formation of different types of tumors. These findings suggest a role for GPR55 signaling in cancer progression.
Scala G +4 more
core
Structural basis for lipid-mediated activation of G protein-coupled receptor GPR55
GPR55 is an orphan G protein-coupled receptor (GPCR) and represents a promising drug target for cancer, inflammation, and metabolic diseases. The endogenous activation of lipid GPCRs can be solely mediated by membrane components and different lipids have
Tobias Claff +5 more
doaj +1 more source
Einfluss von Cannabinoiden auf die Proliferation humaner Glioblastomzellen via GPR55-Rezeptor und GPR55-assoziierter Signalwege [PDF]
Numerous studies reported on tumor suppressive effects of cannabinoids, which were mostly mediated by cannabinoid-specific receptors such as CB1 or CB2.
Kolbe, Marc Richard
core +1 more source
GPR55 is a lipid-responsive G-protein-coupled receptor implicated in metabolic regulation, but its characterization has been limited by the poor selectivity and pathway bias of classical ligands.
Francisco J. Ponce-Díaz +12 more
doaj +1 more source
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management
Dinorah Leyva-Illades,1–3 Sharon DeMorrow1–3 1Digestive Disease Research Center, Scott and White Hospital, Temple, TX, USA; 2Department of Internal MedicineTexas A&M Health Science Center, Temple, TX, USA; 3Research Service, Central Texas
Leyva-Illades D, DeMorrow S
core

